Quarter Period Consolidated Statement Of Comprehensive Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7723663

Concept 2018-03-01 to
2018-05-31
2017-03-01 to
2017-05-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
3,517,000,000 JPY
3,755,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
818,000,000 JPY
1,132,000,000 JPY
Foreign currency translation adjustment
-3,614,000,000 JPY
-2,128,000,000 JPY
Remeasurements of defined benefit plans, net of tax
56,000,000 JPY
65,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-16,000,000 JPY
-23,000,000 JPY
Other comprehensive income
-2,756,000,000 JPY
-952,000,000 JPY
Comprehensive income
761,000,000 JPY
2,802,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
732,000,000 JPY
2,735,000,000 JPY
Comprehensive income attributable to non-controlling interests
28,000,000 JPY
67,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.